Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Ritter

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Cell Calcium|July 5, 2005
Propagation of Ca2+ release in cardiac myocytes: role of mitochondriaHidetaka Seguchi, Michael Ritter, Masaaki Shizukuishi, et al.
Acta Neurochirurgica|November 10, 2012
Unusual clinico-pathological features in primary Hodgkin's lymphomas of the central nervous systemMarco Gessi, Klaus Kuchelmeister, Udo Kellner, et al.
Joint Commission Journal on Quality and Patient Safety|May 14, 2009
Rescue me: saving the vulnerable non-ICU patient populationMary Kay Bader, Beverly Neal, Linda Johnson, et al.
Journal of Water and Health|September 28, 2024
Determinants of adoption of household water treatment in Haiti using two analysis methods: logistic regression and machine learningCamille Heylen, Diona Antoine, Michael Ritter, et al.
American Journal of Physiology. Endocrinology and Metabolism|February 10, 2012
A new transgenic rat model overexpressing the angiotensin II type 2 receptor provides evidence for inhibition of cell proliferation in the outer adrenal cortexBarbara Peters, Dirk Podlich, Michael Ritter, et al.
Human Vaccines & Immunotherapeutics|April 28, 2015
Phase II studies to select the formulation of a multivalent HPV L1 virus-like particle (VLP) vaccineAlain Luxembourg, Darron Brown, Celine Bouchard, et al.
Blood|June 28, 2011
Response of ETV6-FLT3-positive myeloid/lymphoid neoplasm with eosinophilia to inhibitors of FMS-like tyrosine kinase 3Christoph Walz, Philipp Erben, Michael Ritter, et al.
The Lancet. Infectious Diseases|September 3, 2023
Safety, efficacy, and immunogenicity of a replication-defective human cytomegalovirus vaccine, V160, in cytomegalovirus-seronegative women: a double-blind, randomised, placebo-controlled, phase 2b trialRituparna Das, Daniel Blázquez-Gamero, David I Bernstein, et al.
Nature Biomedical Engineering|July 28, 2025
Integrated in vivo combinatorial functional genomics and spatial transcriptomics of tumours to decode genotype-to-phenotype relationshipsMarco Breinig, Artem Lomakin, Elyas Heidari, et al.
Gynecologic Oncology|April 16, 2019
Nine-valent HPV vaccine efficacy against related diseases and definitive therapy: comparison with historic placebo populationAnna R Giuliano, Elmar A Joura, Suzanne M Garland, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Cell Calcium|July 5, 2005
Propagation of Ca2+ release in cardiac myocytes: role of mitochondriaHidetaka Seguchi, Michael Ritter, Masaaki Shizukuishi, et al.
Acta Neurochirurgica|November 10, 2012
Unusual clinico-pathological features in primary Hodgkin's lymphomas of the central nervous systemMarco Gessi, Klaus Kuchelmeister, Udo Kellner, et al.
Joint Commission Journal on Quality and Patient Safety|May 14, 2009
Rescue me: saving the vulnerable non-ICU patient populationMary Kay Bader, Beverly Neal, Linda Johnson, et al.
Journal of Water and Health|September 28, 2024
Determinants of adoption of household water treatment in Haiti using two analysis methods: logistic regression and machine learningCamille Heylen, Diona Antoine, Michael Ritter, et al.
American Journal of Physiology. Endocrinology and Metabolism|February 10, 2012
A new transgenic rat model overexpressing the angiotensin II type 2 receptor provides evidence for inhibition of cell proliferation in the outer adrenal cortexBarbara Peters, Dirk Podlich, Michael Ritter, et al.
Human Vaccines & Immunotherapeutics|April 28, 2015
Phase II studies to select the formulation of a multivalent HPV L1 virus-like particle (VLP) vaccineAlain Luxembourg, Darron Brown, Celine Bouchard, et al.
Blood|June 28, 2011
Response of ETV6-FLT3-positive myeloid/lymphoid neoplasm with eosinophilia to inhibitors of FMS-like tyrosine kinase 3Christoph Walz, Philipp Erben, Michael Ritter, et al.
The Lancet. Infectious Diseases|September 3, 2023
Safety, efficacy, and immunogenicity of a replication-defective human cytomegalovirus vaccine, V160, in cytomegalovirus-seronegative women: a double-blind, randomised, placebo-controlled, phase 2b trialRituparna Das, Daniel Blázquez-Gamero, David I Bernstein, et al.
Nature Biomedical Engineering|July 28, 2025
Integrated in vivo combinatorial functional genomics and spatial transcriptomics of tumours to decode genotype-to-phenotype relationshipsMarco Breinig, Artem Lomakin, Elyas Heidari, et al.
Gynecologic Oncology|April 16, 2019
Nine-valent HPV vaccine efficacy against related diseases and definitive therapy: comparison with historic placebo populationAnna R Giuliano, Elmar A Joura, Suzanne M Garland, et al.
Pageof 4